Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young men

Journal of Clinical Investigation

Volumn 100, Issue 3, 1997, Pages 745-753

  Van Cauter, Eve ^a   Plat, Laurence ^a,c   Scharf, Martin B ^b   Leproult, Rachel ^a   Cespedes, Sonya ^a   L'Hermite Balériaux, Mireille ^c   Copinschi, Georges ^c  

^a UNIVERSITY OF CHICAGO   (United States)

^b Ctr for Research in Sleep Disorders   (United States)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Aging; Cortisol; Delta waves; Growth hormone releasing hormone (GHRH); Prolactin

Indexed keywords

4 HYDROXYBUTYRIC ACID; GROWTH HORMONE; HYDROCORTISONE; MELATONIN; PLACEBO; PROLACTIN; THYROTROPIN;

AGING; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELTA RHYTHM; ENURESIS; GROWTH HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; POLYSOMNOGRAPHY; PRIORITY JOURNAL; SLEEP STAGE; SLEEP WALKING; SLOW WAVE SLEEP;

EID: 0030743575     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119587     Document Type: Article

References (58)

1. Van Cauter, E., and L. Plat. 1996. Physiology of growth hormone during sleep. J. Pediatr. 128:S32-S37.
2. Takahashi, Y., D.M. Kipnis, and W.H. Daughaday. 1968. Growth hormone secretion during sleep. J. Clin. Invest. 47:2079-2090.
3. Sassin, J.F., D.C. Parker, J.W. Mace, R.W. Gotlin, L.C. Johnson, and L.G. Rossman. 1969. Human growth hormone release: relation to slow-wave sleep and sleep-waking cycles. Science (Wash. DC). 165:513-515.
4. Holl, R.W., M.L. Hartmann, J.D. Veldhuis, W.M. Taylor, and M.O. Thorner. 1991. Thirty-second sampling of plasma growth hormone in man: correlation with sleep stages. J. Clin. Endocrinol. Metab. 72:854-861.
5. Ocampo-Lim, B., W. Guo, R. DeMott Friberg, A.L. Barkan, and C.A. Jaffe. 1996. Nocturnal growth hormone (GH) secretion is eliminated by infusion of GH-releasing Hormone antagonist. J. Clin. Endocrinol. Metab. 81:4396-4399.
6. Jarrett, D.B., J.B. Greenhouse, J.M. Miewald, I.B. Fedorka, and D.J. Kupfer. 1990. A reexamination of the relationship between growth hormone secretion and slow wave sleep using delta wave analysis. Biol. Psychiatry. 27:497-509.
7. Born, J., S. Muth, and H.L. Fehm. 1988. The significance of sleep onset and slow wave sleep for nocturnal release of growth hormone (GH) and cortisol. Psychoneuroendocrinology. 13:233-243.
8. McCracken, J.T., R.E. Poland, R.T. Rubin, and L. Tondo. 1991. Dose-dependent effects of scopolamine on nocturnal growth hormones secretion in normal adult men: relation to δ-sleep changes. J. Clin. Endocrinol. Metab. 72: 90-95.
9. Peters, J.R., P.J. Evans, M.D. Page, R. Hall, J.T. Gibbs, C. Dieguez, and M.F. Scanlon. 1986. Cholinergic muscarinic receptor blockade with pirenzepine abolishes slow-wave sleep-related growth hormone release in normal adult males. Clin. Endocrinol. 26:213-217.
10. Van Cauter, E., M. Kerkhofs, A. Caufriez, A. Van Onderbergen, M.O. Thorner, and G. Copinschi. 1992. A quantitative estimation of GH secretion in normal man: reproducibility and relation to sleep and time of day. J. Clin. Endocrinol. Metab. 74:1441-1450.
11. Scharf, M.B. 1992. Pharmacology of classic and novel hypnotic drugs. In Target Receptors for Anxiolytics and Hypnotics: From Molecular Pharmacology to Therapeutics. S.Z. Langer, J. Mendlewicz, and C. Racagni, editors. Karger, Basel. 109-116.
12. Copinschi, G., A. Van Onderbergen, M. L'Hermite-Balériaux, M. Szyper, A. Caufriez, D. Bosson, M. L'Hermite, C. Robyn, F.W. Turek, and E. Van Cauter. 1990. Effects of the short-acting benzodiazepine triazolam, taken at bedtime, on circadian and sleep-related hormonal profiles in normal men. Sleep (Rochester). 13:232-244.
13. Copinschi, G., E. Akseki, R. Moreno-Reyes, R. Leproult, M. L'Hermite-Balériaux, A. Caufriez, F. Vertongen, and E. Van Cauter. 1995. Effects of bedtime administration of zolpidem on circadian and sleep-related hormonal profiles in normal women. Sleep (Rochester). 18:417-424.
14. Mamelak, M., J.M. Escriu, and O. Stokan. 1977. The effects of gamma-hydroxybutyrate on sleep. Biol. Psychiatry. 12:273-288.
15. Lapierre, O., J. Montplaisir, M. Lamarre, and M.A. Bedard. 1990. The effects of gamma-hydroxybutyrate on nocturnal and diurnal sleep of normal subjects: further consideration on REM-sleep triggering mechanisms. Sleep (Rochester). 13:24-30.
16. Series, F., I. Series, and Y. Cormier. 1992. Effects of enhancing slow-wave sleep by gamma-hydroxybutyrate on obstructive sleep apnea. Am. Rev. Respir. Dis. 145:1378-1383.
17. Mamelak, M., M.B. Scharf, and M. Woods. 1986. Treatment of narcolepsy with gamma-hydroxybutyrate. A review of clinical and sleep laboratory findings. Sleep (Rochester). 9:285-289.
18. Scharf, M.B., D. Brown, M. Woods, L. Brown, and J. Hirschowitz. 1985. The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsy. J. Clin. Psychiatry. 46:222-225.
19. Lammers, G.J., J. Arends, A.C. Declerck, M.D. Ferrari, G. Schouwink, and J. Troost. 1993. Gammahydroxybutyrate and narcolepsy: a double-blind placebo-controlled study. Sleep (Rochester). 16:216-220.
20. Mamelak, M. 1989. Gamma-hydroxybutyrate: an endogenous regulator of energy metabolism. Neurosci. Biobehav. Rev. 13:187-198.
21. Tunnicliff, G. 1992. Significance of gamma-hydroxybutyrate in the brain. Gen Pharmacol. 23:1027-1034.
22. Cash, C.D. 1994. Gammahydroxybutyrate: an overview of the pros and cons for it being a neurotransmitter and/or a useful therapeutic agent. Neurosci. Biobehav. Rev. 18:291-304.
23. van Coevorden, A., J. Mockel, E. Laurent, M. Kerkhofs, M. L'Hermite-Balériaux, C. Decoster, P. Nève, and E. Van Cauter. 1991. Neuroendocrine rhythms and sleep in aging. Am. J. Physiol. 260:E651-E661.
24. Veldhuis, J., A. Liem, S. South, A. Weltman, J. Weltman, D. Clemmons, R. Abbott, T. Mulligan, M. Johnson, S. Pincus, et al. 1995. Differential impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay. J. Clin. Endocrinol. Metab. 80:3209-3222.
25. Vermeulen. A. 1987. Nyctohemeral growth hormone profiles in young and aged men: correlation with somatomedin-C levels. J. Clin. Endocrinol. Metab. 64:884-888.
26. Ho, K.Y., W.S. Evans, R.M. Blizzard, J.D. Veldhuis, G.R. Merriam, E. Samojlik, R. Furlanetto, A.D. Rogol, D.L. Kaiser, and M.O. Thorner. 1987. Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J. Clin. Endocrinol. Metab. 64:51-58.
27. Cuneo, R., F. Salomon, G. McGauley, and P. Sonksen. 1992. The growth hormone deficiency syndrome in adults. Clin. Endocrinol. 37:387-397.
28. Corpas, E., S.M. Harman, and M.R. Blackman. 1993. Human growth hormone and human aging. Endocr. Rev. 14:20-39.
29. Rosen, T., T. Hansson, H. Granhed, J. Szucs, and B. Bengtsson. 1993. Reduced bone mineral content in adult patients with growth hormone deficiency. Acta. Endocrinol. 129:201-206.
30. Rechtschaffen, A., and A. Kales. 1968. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Government Printing Office, Washington DC.
31. Stanus, E., B. Lacroix, M. Kerkhofs, and J. Mendlewicz. 1987. Automated sleep scoring: a comparative reliability study of two algorithms. Electroencephalogr. Clin. Neurophysiol. 66:448-456.
32. Stanus, E.L., B.P. Lacroix, M. Kerkhofs, and J. Mendlewicz. 1988. Computer-aided sleep staging in clinical environment. Neuropsychobiology. 20:178-186.
33. Van Cauter, E. 1988. Estimating false-positive and false-negative errors in analyses of hormonal pulsatility. Am. J. Physiol. 254:E786-E794.
34. Faria, A.C.S., J.D. Veldhuis, M.O. Thorner, and M.L. Vance. 1989. Half-time of endogenous growth hormone (GH) disappearance in normal man after stimulation of GH secretion by GH-releasing hormone and suppression with somatostatin. J. Clin. Endocrinol. Metab. 68:535-541.
35. Veldhuis, J.D., A. Iranmanesh, M.L. Johnson, and G. Lizarralde. 1990. Twenty-four-hour rhythms in plasma concentrations of adenohypophyseal hormones are generated by distinct amplitude and/or frequency modulation of underlying pituitary secretory bursts. J. Clin. Endocrinol. Metab. 71:1616-1623.
36. Spiegel, K., M. Follenius, J. Krieger, E. Sforza, and G. Brandenberger. 1995. Prolactin secretion during sleep in obstructive sleep apnea patients. J. Sleep. Res. 4:56-62.
37. Bradley, E.M., and C. Waterhouse. 1966. Effect of estrogen administration on extravascular Cortisol. J. Clin. Endocrinol. Metab. 26:705-714.
38. Van Cauter, E., E.T. Shapiro, H. Tillil, and K.S. Polonsky. 1992. Circadian modulation of glucose and insulin responses to meals: relationship to cortisol rhythm. Am. J. Physiol. 262:E467-E475.
39. Yamada, Y., J. Yamamoto, A. Fujiki, Y. Hishikawa, and Z. Kaneko. 1967. Effect of butyrolactone and gamma-hydroxybutyrate on the EEG and sleep cycle in man. Electroencephalogr. Clin. Neurophysiol. 22:558-562.
40. Gronfier, C., R. Luthringer, M. Follenius, N. Schaltenbrand, J.P. Macher, A. Muzet, and G. Brandenberger. 1996. A quantitative evaluation of the relationships between growth hormone secretion and delta wave electroencephalographic activity during normal sleep and after enrichment in delta waves. Sleep (Rochester). 19:817-824.
41. Krueger, J., and F.J. Obal. 1993. Growth hormone-releasing hormone and interleukin-1 in sleep regulation. FASEB J. 7:645-652.
42. Takahara, J., S. Yunoki, W. Yakushiji, J. Yamauchi, Y. Yamane, and T. Ofuji. 1977. Stimulatory effects of gamma-hydroxybutyric acid on growth hormone and prolactin release in humans. J. Clin. Endocrinol. Metab. 44:1014-1017.
43. Scrima, L., P.G. Hartman, F.H. Johnson, E.F. Thomas, and F.C. Hiller. 1990. The effects of gamma-hydroxybutyrate on the sleep of narcolepsy patients: a double blind study. Sleep (Rochester). 13:479-490.
44. Gerra, G., R. Caccavari, B. Fontanesi, A. Marcato, G. Fertonani Affini, D. Maestri, P. Avanzini, R. Lecchini, R. Delsignore, and A. Mutti. 1994. Flumazenil effects on growth hormone response to gamma-hydroxybutyric acid. Int. J. Clin. Psychopharmacol. 9:211-215.
45. Gallimberti, L., M. Cibin, P. Pagnin, R. Sabbion, P.P. Pani, R. Pirasta, S.D. Ferrara, and G.L. Gessa. 1993. Gamma-hydroxybutyric acid for treatment of opiate withdrawal syndrome. Neuropsychopharmacology. 9:77-81.
46. Dyer, J.E. 1991. Gamma-hydroxybutyrate: a health-food producing coma and seizure-like activity. Am. J. Emerg. Med. 1991:321-324.
47. Chin, M.Y., R.A. Kreutzer, and J.E. Dyer. 1992. Acute poisoning from gamma-hydroxybutyrate in California. West. J. Med. 156:380-384.
48. Steele, M.T., and W.A. Watson. 1995. Acute poisoning from gammahydroxybutyrate (GHB). MO. Med. 92:354-357.
49. Ross, T.M. 1995. Gamma-hydroxybutyrate overdose: two cases illustrate the unique aspects of this dangerous recreational drug. J. Emerg. Nurs. 21: 374-376.
50. Friedman, J., R. Westlake, and M. Furman. 1996. "Grievous bodily harm": Gamma-hydroxybutyrate abuse leading to a Wernicke-Korsafoff syndrome. Neurology. 46:469-471.
51. Spiegel, K., R. Luthringer, M. Follenius, N. Schaltenbrand, J.P. Macher, A. Muzet, and G. Brandenberger. 1995. Temporal relationship between prolactin secretion and slow-wave electroencephalographic activity during sleep. Sleep (Rochester). 18:543-548.
52. Rudman, D., A.G. Feller, H.S. Nagraj, G.A. Gergans, P.Y. Lalitha, A.F. Goldberg, R.A. Schlenker, L. Cohn, Y.W. Rudman, and D.E. Mattson. 1990. Effects of human growth hormone in men over 60 years old. N. Engl. J. Med. 323:1-6.
53. Rudman, D., A.G. Feller, L. Cohn, K.R. Shetty, I.W. Rudman, and M.W. Draper. 1991. Effects of human growth hormone on body composition in elderly men. Horm. Res. (Basel). 36(Suppl. 1):73-81.
54. Marcus, R., G. Butterfield, L. Holloway, L. Gilliland, D.J. Baylink, R.L. Hinz, and B.M. Sherman. 1990. Effects of short term administration of recombinant human growth hormone to elderly people. J. Clin. Endocrinol. Metab. 70:519-527.
55. Papadakis, M.A., D. Grady, and D. Black. 1996. Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann. Intern. Med. 124:708-716.
56. Bowers, C.Y. 1994. On a peptidomimetic growth hormone-releasing peptide. J. Clin. Endocrinol. Metab. 79:940-942.
57. Saenger, P. 1996. Oral growth hormone secretagogues - better than Alice in Wonderland's growth elixir? J. Clin. Endocrinol. Metab. 81:2773-2775.
58. Chapman, I.A., M.A. Bach, E. Van Cauter, M. Farmer, D. Krupa, A.M. Taylor, L.M. Schilling, K.Y. Cole, E.H. Skyles, S.S. Pezzoli, et al. 1996. Stimulation of the growth hormone (GH)-insulin-like growth factor-I axis by daily oral administration of a GH secretagogue (MK-677) in healthy elderly subjects. J. Clin. Endocrinol. Metab. 81:4249-4257.